Industry Perspectives:

Alison (Ali) Holland is Head of Decentralized Clinical Trials at Medable and is chartered to design and expand the end-to-end capabilities.

As Chief Scientific Officer, Dr. Pamela Tenaerts oversees Medable’s clinical research department to help identify, develop and implement...

With eConsent continuing to make in-roads with trials across the globe, many sponsors have found themselves challenged by evolving regulations, data standards, participant preferences and new ways of working, making it difficult to plan for success. 

In this webinar, we’ll sit down with industry experts Alison Holland and Pamela Tenaerts to dive into the current state of eConsent and Televisit solutions around the world as well as lessons learned from our latest study completions and best practices for the future. 

If you’re curious to learn more about how you can navigate the evolving eConsent landscape and set up your studies for success then don’t wait! 

Best Practices on how to Navigate the Evolving eConsent and DCT Landscape In 2021